NCT03499808 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 35
- units
- Participants
- groups
- description
- Patients receive isatuximab IV on days 1, 8, 15, and 22 of course 1 and on days 1 and 15 of subsequent courses. Treatment repeats every 28 days for 24 courses in the absence of disease progression or unacceptable toxicity. Isatuximab: Given IV Laboratory Biomarker Analysis: Correlative studies
- id
- BG000
- title
- Treatment (Isatuximab)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 40.1
- upper Limit
- 79.5
- value
- 70
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Female
- measurements
- group Id
- BG000
- value
- 19
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 32
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 29
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- PS 0
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- PS 1
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- PS 2
- description
- PS 0 - Fully active, able to carry on all pre-disease performance without restriction PS 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. PS 2- Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- Kappa
- measurements
- group Id
- BG000
- value
- 23
- title
- Lambda
- measurements
- group Id
- BG000
- value
- 1
- title
- None
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Involved Light Chain
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 141
- upper Limit
- 1689
- value
- 700
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- IgG (mg/dL)
- unit Of Measure
- mg/dL
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- title
- Single Organ Involvement
- measurements
- group Id
- BG000
- value
- 17
- title
- Multiple Organ involvement
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Organ Involvement
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Stage I
- measurements
- group Id
- BG000
- value
- 8
- title
- Stage II
- measurements
- group Id
- BG000
- value
- 8
- title
- Stage III
- measurements
- group Id
- BG000
- value
- 1
- title
- Stage IV
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 10
- title
- Not assessed - no cardiac involvement at baseline
- description
- Stage I: all below cutoff Stage II: 1 above Stage III: 2 above Stage IV: 3 above cTnT ≥0.025 ng/ml NT-proBNP ≥1,800 pg/ml FLC-diff ≥18 mg/dl
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Mayo Cardiac Biomarker Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0
- upper Limit
- 30
- value
- 6
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Plasma Cells (%, Bone Marrow)
- unit Of Measure
- % of Bone Marrow
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- Yes
- measurements
- group Id
- BG000
- value
- 21
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Kidney Involvement
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Yes
- measurements
- group Id
- BG000
- value
- 26
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Nervous System Involvement
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 35
- units
- Participants
- groups
- description
- Patients receive isatuximab IV on days 1, 8, 15, and 22 of course 1 and on days 1 and 15 of subsequent courses. Treatment repeats every 28 days for 24 courses in the absence of disease progression or unacceptable toxicity. Isatuximab: Given IV Laboratory Biomarker Analysis: Correlative studies
- id
- BG000
- title
- Treatment (Isatuximab)
- measures
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 40.1
- upper Limit
- 79.5
- value
- 70
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- title
- Female
- measurements
- group Id
- BG000
- value
- 19
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 32
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 2
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 1
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 1
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 29
- title
- White
- measurements
- group Id
- BG000
- value
- 0
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 4
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 8
- title
- PS 0
- categories
- measurements
- group Id
- BG000
- value
- 25
- title
- PS 1
- categories
- measurements
- group Id
- BG000
- value
- 2
- title
- PS 2
- description
- PS 0 - Fully active, able to carry on all pre-disease performance without restriction PS 1 - Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light housework, office work. PS 2- Ambulatory and capable of self-care but unable to carry out any work activities; up and about more than 50% of waking hours.
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Performance Status
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 10
- title
- Kappa
- measurements
- group Id
- BG000
- value
- 23
- title
- Lambda
- measurements
- group Id
- BG000
- value
- 1
- title
- None
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Involved Light Chain
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 141
- upper Limit
- 1689
- value
- 700
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- IgG (mg/dL)
- unit Of Measure
- mg/dL
- classes
- categories
- measurements
- group Id
- BG000
- value
- 18
- title
- Single Organ Involvement
- measurements
- group Id
- BG000
- value
- 17
- title
- Multiple Organ involvement
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Organ Involvement
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 7
- title
- Stage I
- measurements
- group Id
- BG000
- value
- 8
- title
- Stage II
- measurements
- group Id
- BG000
- value
- 8
- title
- Stage III
- measurements
- group Id
- BG000
- value
- 1
- title
- Stage IV
- measurements
- group Id
- BG000
- value
- 1
- title
- Unknown
- measurements
- group Id
- BG000
- value
- 10
- title
- Not assessed - no cardiac involvement at baseline
- description
- Stage I: all below cutoff Stage II: 1 above Stage III: 2 above Stage IV: 3 above cTnT ≥0.025 ng/ml NT-proBNP ≥1,800 pg/ml FLC-diff ≥18 mg/dl
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Mayo Cardiac Biomarker Stage
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0
- upper Limit
- 30
- value
- 6
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Plasma Cells (%, Bone Marrow)
- unit Of Measure
- % of Bone Marrow
- classes
- categories
- measurements
- group Id
- BG000
- value
- 14
- title
- Yes
- measurements
- group Id
- BG000
- value
- 21
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Kidney Involvement
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 9
- title
- Yes
- measurements
- group Id
- BG000
- value
- 26
- title
- No
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Nervous System Involvement
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle